ALOX12 and colorectal cancer: ALOX12 has been identified a biomarker and therapeutic target in many human malignancies [33]; it is closely linked to the prognosis, tumor proliferation, invasion, and metastasis of colorectal cancer, and its high expression predicts a better immunotherapy response [34].